Literature DB >> 18550875

Clinical practice. Graves' disease.

Gregory A Brent1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550875     DOI: 10.1056/NEJMcp0801880

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  137 in total

Review 1.  Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab.

Authors:  Laszlo Hegedüs; Terry J Smith; Raymond S Douglas; Claus H Nielsen
Journal:  Clin Endocrinol (Oxf)       Date:  2011-01       Impact factor: 3.478

2.  Diseases as natural kinds.

Authors:  Stefan Dragulinescu
Journal:  Theor Med Bioeth       Date:  2010-10

3.  37-year-old woman with palpitations and fatigue.

Authors:  Amit Noheria; Sahil Khanna; Colin P West
Journal:  Mayo Clin Proc       Date:  2011-01       Impact factor: 7.616

4.  Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease.

Authors:  Terry J Smith; Dolly A Padovani-Claudio; Ying Lu; Nupur Raychaudhuri; Roshini Fernando; Stephen Atkins; Erin F Gillespie; Andrew G Gianoukakis; Barbra S Miller; Paul G Gauger; Gerard M Doherty; Raymond S Douglas
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

5.  A Rare Clinical Manifestation of Graves' Disease: Evans Syndrome and a Review of the Literature.

Authors:  M Calapkulu; M E Sencar; A Yıldız; I O Unsal; E Cakal
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

Review 6.  Diagnosis and management of Graves disease: a global overview.

Authors:  Luigi Bartalena
Journal:  Nat Rev Endocrinol       Date:  2013-10-15       Impact factor: 43.330

7.  Ocular changes and approaches of ophthalmopathy in basedow - graves- parry- flajani disease.

Authors:  George Saraci; Anamaria Treta
Journal:  Maedica (Buchar)       Date:  2011-04

8.  Ameliorative effect of Aloe gel against L-T4-induced hyperthyroidism via suppression of thyrotropin receptors, inflammation and oxidative stress.

Authors:  Sunanda Panda; Rajesh Sharma; Aarif Khan; Anand Kar
Journal:  Mol Biol Rep       Date:  2020-04-03       Impact factor: 2.316

Review 9.  Prevalence and natural history of Graves' orbitopathy in the XXI century.

Authors:  E Piantanida; M L Tanda; A Lai; L Sassi; L Bartalena
Journal:  J Endocrinol Invest       Date:  2013-04-16       Impact factor: 4.256

10.  Pentraxin-3 Is a TSH-Inducible Protein in Human Fibrocytes and Orbital Fibroblasts.

Authors:  Hao Wang; Stephen J Atkins; Roshini Fernando; Rui-Li Wei; Terry J Smith
Journal:  Endocrinology       Date:  2015-08-19       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.